Patents by Inventor Boris Julien

Boris Julien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Speed reduction gear for an aircraft turbomachine
    Patent number: 11933229
    Abstract: Speed reduction gear for an aircraft turbomachine. The reduction gear has a main axis and planet carrier having a cage and a cage carrier, a sun gear located in the cage and centred on the main axis, an annular row of planet gears arranged around the main axis and the sun gear and meshed with the sun gear, and a ring gear arranged around the axis and the cage and meshed with the planet gears. The cage and the cage carrier are connected to each other by connections whose bending flexibility is optimised.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: March 19, 2024
    Assignee: SAFRAN TRANSMISSION SYSTEMS
    Inventors: Patrice Julien Ptaszynski, Antoine Jacques Marie Pennacino, Boris Pierre Marcel Morelli
  • Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases
    Patent number: 8604060
    Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino5 5-(4-chlorophenyl)-1-(2, 4-dichloropenyl)-4-methylpyrazole-3-carboxamide.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: December 10, 2013
    Assignees: INSERM, Sanofi
    Inventors: Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne V. Nhieu
  • USE OF ANTAGONISTS OF THE CBI RECEPTOR FOR THE MANUFACTURE OF A COMPOSITION USEFUL FOR THE TREATMENT OF HEPATIC DISEASES
    Publication number: 20120329833
    Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino5 5-(4-chlorophenyl)-1-(2, 4-dichloropenyl)-4-methylpyrazole-3-carboxamide.
    Type: Application
    Filed: June 28, 2012
    Publication date: December 27, 2012
    Applicants: SANOFI-AVENTIS, INSERM
    Inventors: Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne V. Nhieu
  • Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
    Patent number: 8236763
    Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: August 7, 2012
    Assignees: Inserm, Sanofi-Aventis
    Inventors: Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu
  • CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver
    Patent number: 7906156
    Abstract: Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has liver fibrosis.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: March 15, 2011
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat, Sophie Lotersztajn
  • CB2 RECEPTORS BLOCKS ACCUMULATION OF HUMAN HEPATIC MYOFIBROBLASTS: A NOVEL ANTIFIBROGENIC PATHWAY IN THE LIVER
    Publication number: 20090221692
    Abstract: Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has liver fibrosis.
    Type: Application
    Filed: February 26, 2009
    Publication date: September 3, 2009
    Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: PASCALE GRENARD, BORIS JULIEN, JEANNE TRAN VAN NHIEU, ARIANE MALLAT, SOPHIE LOTERSZTAJN
  • Use of Antagonists of the Cbi Receptor For the Manufacture of a Composition Useful For the Treatment of Hepatic Diseases
    Publication number: 20080214449
    Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
    Type: Application
    Filed: March 8, 2005
    Publication date: September 4, 2008
    Applicants: Inserm, Sandofi-Aventis
    Inventors: Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne V. Nhieu
  • CB2 RECEPTORS BLOCKS ACCUMULATION OF HUMAN HEPATIC MYOFIBROBLASTS: A NOVEL ANTIFIBROGENIC PATHWAY IN THE LIVER
    Publication number: 20080194674
    Abstract: Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has non-alcoholic steatohepatitis.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 14, 2008
    Applicant: Institut National de la Sante et de la Recherche Medicale
    Inventors: Pascale Grenard, Boris Julien, Jean Tran Van Nhieu, Ariane Mallat, Sophie Lotersztajn
  • CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver
    Patent number: 7320805
    Abstract: Methods and compositions for treating diseases mediated by CB2 receptors are disclosed, including fibrosis associated with liver injury.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: January 22, 2008
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat, Sophie Lotersztajn
  • CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver
    Publication number: 20050143448
    Abstract: Methods and compositions for treating diseases mediated by CB2 receptors are disclosed, including fibrosis associated with liver injury.
    Type: Application
    Filed: October 1, 2004
    Publication date: June 30, 2005
    Inventors: Pascale Grenard, Boris Julien, Jean Van Nhieu, Ariane Mallat, Sophie Lotersztajn